Literature DB >> 20855881

NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25.

Gerard E Kaiko1, Simon Phipps, Pornpimon Angkasekwinai, Chen Dong, Paul S Foster.   

Abstract

Severe respiratory syncytial virus (RSV) infection has long been associated with an increased risk for the development of childhood asthma and exacerbations of this disorder. Despite much research into the induction of Th2 responses by allergens and helminths, the factors associated with viral infection that predispose to Th2-regulated asthma remain unknown. Recently, clinical studies have shown reduced numbers of NK cells in infants suffering from a severe RSV infection. Here we demonstrate that NK cell deficiency during primary RSV infection of BALB/c mice results in the suppression of IFN-γ production and the development of an RSV-specific Th2 response and subsequent allergic lung disease. The outgrowth of the Th2 responses was dependent on airway epithelial cell-derived IL-25, which induced the upregulation of the notch ligand Jagged1 on dendritic cells. This study identifies a novel pathway underlying viral-driven Th2 responses that may have functional relevance to viral-associated asthma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855881     DOI: 10.4049/jimmunol.1001758

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Dynamic role of epithelium-derived cytokines in asthma.

Authors:  Kathleen R Bartemes; Hirohito Kita
Journal:  Clin Immunol       Date:  2012-03-20       Impact factor: 3.969

Review 2.  The airway epithelium in asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 3.  Clinical view on the importance of dendritic cells in asthma.

Authors:  Rohit Gaurav; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2013-10       Impact factor: 4.473

4.  The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice.

Authors:  Mingyuan Han; Charu Rajput; Jun Y Hong; Jing Lei; Joanna L Hinde; Qian Wu; J Kelley Bentley; Marc B Hershenson
Journal:  J Immunol       Date:  2017-07-12       Impact factor: 5.422

Review 5.  Tissue-specific effector functions of innate lymphoid cells.

Authors:  Niklas K Björkström; Eliisa Kekäläinen; Jenny Mjösberg
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

6.  IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease.

Authors:  Bryan C Petersen; Vladislav Dolgachev; Andrew Rasky; Nicholas W Lukacs
Journal:  J Leukoc Biol       Date:  2014-01-09       Impact factor: 4.962

Review 7.  Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations.

Authors:  Rakesh K Kumar; Paul S Foster; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2014-06-05       Impact factor: 4.962

8.  IL-17RB+ granulocytes are associated with airflow obstruction in asthma.

Authors:  Lin Li; Nicholas W Lukacs; Matthew A Schaller; Bryan Petersen; Alan P Baptist
Journal:  Ann Allergy Asthma Immunol       Date:  2016-12       Impact factor: 6.347

9.  Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway.

Authors:  Sophia Davidson; Gerard Kaiko; Zhixuan Loh; Amit Lalwani; Vivian Zhang; Kirsten Spann; Shen Yun Foo; Nicole Hansbro; Satoshi Uematsu; Shizuo Akira; Klaus I Matthaei; Helene F Rosenberg; Paul S Foster; Simon Phipps
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

10.  STAT5-induced lunatic fringe during Th2 development alters delta-like 4-mediated Th2 cytokine production in respiratory syncytial virus-exacerbated airway allergic disease.

Authors:  Sumanta Mukherjee; Andrew J Rasky; Phil A Lundy; Nicolai A Kittan; Steven L Kunkel; Ivan P Maillard; Paul E Kowalski; Philaretos C Kousis; Cynthia J Guidos; Nicholas W Lukacs
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.